Figure 6: Effect of MβCD, NAC and TQ416 on cell viability in C12-HSL-treated LS174T cells.

(A) MTT assay of cell viability in AHL- and MβCD-treated LS174T cells, (B) MTT assay of cell viability in AHLs- and NAC-treated LS174T cells and (C) MTT assay of cell viability in AHLs- and TQ416-treated LS174T cells. Values are presented as mean ± SEM (n = 6) and expressed as percentage increase in (A) MβCD, (B) NAC and (C) TQ416. *p < 0.05, ***p < 0.001 versus DMSO group.